Improved Inhibitors Targeting the Thymidylate Kinase of Multidrug-Resistant Mycobacterium tuberculosis with Favorable Pharmacokinetics.

Konate S, Allangba KNPG, Fofana I, N'Guessan RK, Megnassan E, Miertus S, Frecer V

Open source

DOI
10.3390/life15020173
Published
2025 Jan 25
Container
Life (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/life15020173,
  title = {Improved Inhibitors Targeting the Thymidylate Kinase of Multidrug-Resistant Mycobacterium tuberculosis with Favorable Pharmacokinetics.},
  author = {Konate S and Allangba KNPG and Fofana I and N'Guessan RK and Megnassan E and Miertus S and Frecer V},
  year = {2025},
  journal = {Life (Basel, Switzerland)},
  doi = {10.3390/life15020173},
  url = {https://doi.org/10.3390/life15020173}
}

RIS

TY  - JOUR
TI  - Improved Inhibitors Targeting the Thymidylate Kinase of Multidrug-Resistant Mycobacterium tuberculosis with Favorable Pharmacokinetics.
AU  - Konate S
AU  - Allangba KNPG
AU  - Fofana I
AU  - N'Guessan RK
AU  - Megnassan E
AU  - Miertus S
AU  - Frecer V
PY  - 2025
JO  - Life (Basel, Switzerland)
DO  - 10.3390/life15020173
UR  - https://doi.org/10.3390/life15020173
ER  - 

APA

S, K., KNPG, A., I, F., RK, N., E, M., S, M., & V, F. (2025). Improved Inhibitors Targeting the Thymidylate Kinase of Multidrug-Resistant Mycobacterium tuberculosis with Favorable Pharmacokinetics.. Life (Basel, Switzerland). https://doi.org/10.3390/life15020173

Source records